DIFFUSE MIDLINE GLIOMA, H3 K27M-MUTANT

Clinical trials for DIFFUSE MIDLINE GLIOMA, H3 K27M-MUTANT explained in plain language.

Never miss a new study

Get alerted when new DIFFUSE MIDLINE GLIOMA, H3 K27M-MUTANT trials appear

Sign up with your email to follow new studies for DIFFUSE MIDLINE GLIOMA, H3 K27M-MUTANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 12 Not yet recruiting 2 Not yet finished but already full! 1

New drug joins fight against deadly brain tumors

Disease control Terminated

This early-stage study is testing whether adding an experimental drug called S-Gboxin to standard brain cancer treatment helps control aggressive tumors like glioblastoma. It will involve about 10 patients with these difficult-to-treat cancers. Researchers will monitor how patien…

Matched conditions: DIFFUSE MIDLINE GLIOMA, H3 K27M-MUTANT

Phase: PHASE1 • Sponsor: Petrov, Andrey • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

DIFFUSE MIDLINE GLIOMA, H3 K27M-MUTANT

Get alerted when new DIFFUSE MIDLINE GLIOMA, H3 K27M-MUTANT trials appear

New drug joins fight against deadly brain tumors